488 related articles for article (PubMed ID: 26640330)
1. Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.
Quetglas EG; Mujagic Z; Wigge S; Keszthelyi D; Wachten S; Masclee A; Reinisch W
World J Gastroenterol; 2015 Nov; 21(44):12519-43. PubMed ID: 26640330
[TBL] [Abstract][Full Text] [Related]
2. On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance.
Van Asseldonk DP; de Boer NK; Peters GJ; Veldkamp AI; Mulder CJ; Van Bodegraven AA
Curr Drug Metab; 2009 Nov; 10(9):981-97. PubMed ID: 20214590
[TBL] [Abstract][Full Text] [Related]
3. Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
Papamichael K; Osterman MT; Siegel CA; Melmed GY; Dubinsky MC; Colombel JF; Hanauer SB; Cheifetz AS
Gastroenterology; 2018 Mar; 154(4):1201-1202. PubMed ID: 29432749
[No Abstract] [Full Text] [Related]
4. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Patient Guide.
American Gastroenterological Association
Gastroenterology; 2017 Sep; 153(3):860-861. PubMed ID: 28774545
[No Abstract] [Full Text] [Related]
5. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Clinical Decision Support Tool.
American Gastroenterological Association
Gastroenterology; 2017 Sep; 153(3):858-859. PubMed ID: 28778399
[No Abstract] [Full Text] [Related]
6. American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
Feuerstein JD; Nguyen GC; Kupfer SS; Falck-Ytter Y; Singh S;
Gastroenterology; 2017 Sep; 153(3):827-834. PubMed ID: 28780013
[No Abstract] [Full Text] [Related]
7. An update on biosimilar drugs for inflammatory bowel disease.
Schreiber S
Expert Rev Gastroenterol Hepatol; 2015; 9 Suppl 1():1-3. PubMed ID: 26395529
[TBL] [Abstract][Full Text] [Related]
8. Current stage in inflammatory bowel disease: What is next?
Gómez-Gómez GJ; Masedo Á; Yela C; Martínez-Montiel Mdel P; Casís B
World J Gastroenterol; 2015 Oct; 21(40):11282-303. PubMed ID: 26525013
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of mean corpuscular volume as a surrogate marker for monitoring thiopurine treatment in inflammatory bowel disease.
Dujardin RW; Meijer B; de Boer NK; D'Haens GR; Löwenberg M
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):991-6. PubMed ID: 27257870
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis of inflammatory bowel diseases: functional role of T cells and T cell homing.
Zundler S; Neurath MF
Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S19-28. PubMed ID: 26458165
[TBL] [Abstract][Full Text] [Related]
11. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
[TBL] [Abstract][Full Text] [Related]
12. A validated HPLC method for the monitoring of thiopurine metabolites in whole blood in paediatric patients with inflammatory bowel disease.
Cangemi G; Barabino A; Barco S; Parodi A; Arrigo S; Melioli G
Int J Immunopathol Pharmacol; 2012; 25(2):435-44. PubMed ID: 22697075
[TBL] [Abstract][Full Text] [Related]
13. Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.
Quetglas EG; Armuzzi A; Wigge S; Fiorino G; Barnscheid L; Froelich M; Danese S
Eur J Clin Pharmacol; 2015 Jul; 71(7):773-99. PubMed ID: 26008212
[TBL] [Abstract][Full Text] [Related]
14. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.
Jiang W; Li X
Mol Diagn Ther; 2015 Jun; 19(3):141-58. PubMed ID: 25990388
[TBL] [Abstract][Full Text] [Related]
15. [Update: chronic inflammatory bowel disease].
Atreya R; Neumann H; Neurath MF
Dtsch Med Wochenschr; 2015 Nov; 140(23):1762-72. PubMed ID: 26583823
[TBL] [Abstract][Full Text] [Related]
16. Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease.
Strik AS; Bots SJ; D'Haens G; Löwenberg M
Expert Rev Clin Pharmacol; 2016; 9(3):429-39. PubMed ID: 26681400
[TBL] [Abstract][Full Text] [Related]
17. Vitamin A and inflammatory bowel diseases: from cellular studies and animal models to human disease.
Barbalho SM; Goulart RA; Batista GLDSA
Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):25-35. PubMed ID: 30791845
[TBL] [Abstract][Full Text] [Related]
18. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease.
Farzaei MH; Bahramsoltani R; Abdolghaffari AH; Sodagari HR; Esfahani SA; Rezaei N
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):745-58. PubMed ID: 26799847
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in gastrointestinal disorders.
Camilleri M; Saito YA
Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
[TBL] [Abstract][Full Text] [Related]
20. Potential role of nutraceutical compounds in inflammatory bowel disease.
Larussa T; Imeneo M; Luzza F
World J Gastroenterol; 2017 Apr; 23(14):2483-2492. PubMed ID: 28465632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
